Trial
NCT04931420
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Metastatic Cancer
Intervention
Standard of Care Chemotherapy
Why stopped
PI left site
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-31